| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
9,230,000 |
| Market
Cap: |
3.60(M) |
| Last
Volume: |
426,351 |
Avg
Vol: |
425,187 |
| 52
Week Range: |
$0.39 - $0.39 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Cyclacel Pharmaceuticals is a clinical-stage biopharmaceutical company working to develop cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. The anti-mitotic program is evaluating CYC140, a Polo-Like-Kinase 1(PLK 1) inhibitor, in cancers. CDKs are a family of enzymes discovered as regulators of the cell cycle. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle, and is a regulator of the DNA damage checkpoint.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
7,956 |
7,956 |
7,956 |
| Total Buy Value |
$0 |
$26,374 |
$26,374 |
$26,374 |
| Total People Bought |
0 |
2 |
2 |
2 |
| Total Buy Transactions |
0 |
2 |
2 |
2 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Morgan Stanley |
10% Owner |
– – • |
2009-11-02 |
4 |
B |
$0.87 |
$3,741 |
I/I |
4,300 |
2,780,024 |
1.42 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-11-02 |
4 |
S |
$0.87 |
$3,741 |
I/I |
(4,300) |
2,775,724 |
|
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-10-08 |
4 |
B |
$0.84 |
$840 |
I/I |
1,000 |
3,992,624 |
1.42 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-10-01 |
4 |
S |
$0.90 |
$51,480 |
I/I |
(57,200) |
2,780,024 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-10-01 |
4 |
B |
$0.90 |
$51,480 |
I/I |
57,200 |
2,837,224 |
1.5 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-09-04 |
4 |
B |
$0.84 |
$4,956 |
I/I |
5,900 |
3,991,624 |
1.42 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-09-03 |
4 |
B |
$0.84 |
$32,760 |
I/I |
39,000 |
3,985,724 |
1.5 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-09-02 |
4 |
B |
$0.83 |
$158,600 |
I/I |
190,400 |
3,946,724 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-09-01 |
4 |
S |
$0.87 |
$6,264 |
I/I |
(7,200) |
2,780,024 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-09-01 |
4 |
B |
$0.87 |
$6,264 |
I/I |
7,200 |
2,787,224 |
1.5 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-09-01 |
4 |
B |
$0.84 |
$58,611 |
I/I |
70,000 |
3,756,324 |
1.5 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-08-31 |
4 |
B |
$0.84 |
$33,023 |
I/I |
39,266 |
3,686,324 |
1.5 |
- |
|
| Marxe Austin W & Greenhouse David M |
10% Owner |
– – • |
2009-07-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,647,058 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-05-01 |
4 |
S |
$0.61 |
$1,952 |
I/I |
(3,200) |
2,780,024 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-05-01 |
4 |
B |
$0.61 |
$1,952 |
I/I |
3,200 |
2,783,224 |
1.42 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-04-01 |
4 |
S |
$0.32 |
$45,490 |
I/I |
(135,420) |
2,780,024 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-04-01 |
4 |
B |
$0.36 |
$19,404 |
I/I |
53,900 |
2,833,924 |
1.5 |
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-03-31 |
4 |
S |
$0.35 |
$6,930 |
I/I |
(19,800) |
2,861,544 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-03-30 |
4 |
S |
$0.35 |
$15,253 |
I/I |
(43,580) |
2,881,344 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-03-27 |
4 |
S |
$0.39 |
$7,644 |
I/I |
(19,600) |
2,924,924 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-03-26 |
4 |
S |
$0.40 |
$11,360 |
I/I |
(28,400) |
2,944,524 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-03-25 |
4 |
S |
$0.40 |
$7,560 |
I/I |
(18,900) |
2,972,924 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-01-02 |
4 |
S |
$0.42 |
$25,326 |
I/I |
(60,300) |
2,991,824 |
|
- |
|
| Morgan Stanley |
10% Owner |
– – • |
2009-01-02 |
4 |
B |
$0.42 |
$25,326 |
I/I |
60,300 |
3,052,124 |
1.5 |
- |
|
| Rombotis Spiro |
President & C.E.O. |
• • – |
2008-12-02 |
4 |
B |
$0.37 |
$1,110 |
D/D |
3,000 |
441,548 |
2.73 |
- |
|
281 Records found
|
|
Page 4 of 12 |
|
|
